Torcetrapib/atorvastatin: Preliminary Phase III data

Preliminary data from a double-blind Phase III trial in 437 patients with heterozygous familial hypercholesterolemia (HeFH) showed that

Read the full 181 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE